Thu, May 19, 2022
Wed, May 18, 2022
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022

Matthew Harrison Maintained (TSVT) at Buy with Decreased Target to $31 on, May 17th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-31-on-may-17th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $36 to $31 on, May 17th, 2022.

Matthew has made no other calls on TSVT in the last 4 months.



There are 2 other peers that have a rating on TSVT. Out of the 2 peers that are also analyzing TSVT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $26 on, Monday, May 2nd, 2022
  • Daina Graybosch of "SVB Leerink" Initiated at Buy and Held Target at $38 on, Thursday, February 10th, 2022

Publication Contributing Sources